Chronic Hypoparathyroidism Associated With Normal, Low-Risk Pregnancy Outcomes
The goal of this study was to evaluate pregnancy outcome and total number of births in chronic hypoparathyroidism.
The goal of this study was to evaluate pregnancy outcome and total number of births in chronic hypoparathyroidism.
This report provides an update on the use of diagnostic tests for asymptomatic primary hyperparathyroidism in clinical practice.
Serum intact parathyroid hormone levels may be an early marker to predict postthyroidectomy hypocalcemia.
TransCon PTH is a long-acting prodrug of parathyroid hormone designed to restore PTH to physiologic levels, normalizing blood and urinary calcium levels, serum phosphate levels and bone turnover.
Investigators examined whether short-term treatment with an angiotensin II receptor blocker and/or vitamin D3 reduced PTH levels.
Vitamin D levels in preterm infants are significantly correlated with optimal calcium homeostasis and bone mineralization of the femur.
Shear wave elastography can be a useful tool in the preliminary diagnostics of parathyroid adenomas.
While parathyroid hormone levels may be used to anticipate calcium decline, a “normal” PTH level does not always correctly predict postoperative calcium level.
After parathyroidectomy, morbidity and mortality rates were considerably higher in patients with secondary and tertiary vs primary hyperparathyroidism.
Etelcalcetide shows promise for reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.